Claire Liefferinckx

Statistics

Publications

Citations

610

H-Index

Active since

2017

Affiliations

Erasmus Hospital(Current)

KU Leuven

Université Libre de Bruxelles

Inserm

University of Liège

Claire Liefferinckx is an author at Erasmus Hospital specializing in inflammatory bowel disease, inflammatory disease pharmacotherapy, and inflammation.

ORCID

Publications per year

2017–2022

Publications

Large-scale sequencing identifies multiple genes and rare variants associated with Crohn’s disease susceptibility

Aleksejs Sazonovs, Christine Stevens, Guhan Venkataraman et al. · Nature Genetics · 2022 · 189 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Long-term Clinical Effectiveness of Ustekinumab in Patients with Crohn’s Disease Who Failed Biologic Therapies: A National Cohort Study

Claire Liefferinckx, Bram Verstockt, Ann Gils et al. · Journal of Crohn s and Colitis · 2019 · 120 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

Effectiveness of ustekinumab dose escalation in Crohn’s disease patients with insufficient response to standard‐dose subcutaneous maintenance therapy

Uri Kopylov, Jurij Hanžel, Claire Liefferinckx et al. · Alimentary Pharmacology & Therapeutics · 2020 · 80 citations · Full text

Medicine, Pharmacology, Clinical Pharmacology +5

Variability of Faecal Calprotectin in Inflammatory Bowel Disease Patients: An Observational Case-control Study

Anneline Cremer, Jade Ku, Leila Amininejad et al. · Journal of Crohn s and Colitis · 2019 · 33 citations · Full text

Medicine, Clinical Sciences, Immunology +15

Early vedolizumab trough levels at induction in inflammatory bowel disease patients with treatment failure during maintenance

Claire Liefferinckx, Charlotte Minsart, Anneline Cremer et al. · European Journal of Gastroenterology & Hepatology · 2019 · 32 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

1–5 of 15